Pfizer says that it "hit the sweet spot" with its coronavirus vaccine for children ages 5 to 11. CBS News' Mola Lenghi reports that the company will be applying for emergency use authorization by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results